Bionano Genomics Inc

Research Bionano Genomics Inc (BNGO) on Bullrun: market cap USD 13.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBNGO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Instruments & Supplies
• CurrencyUSD
• Market capUSD 13.43M
• Financial periodFY2025
• RevenueUSD 28.51M
• Revenue growth-7.4%
• Net income-USD 26.40M
• Gross margin46.3%

Valuation Snapshot

latest market cap is USD 13.43M.

About Bionano Genomics Inc

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

Frequently asked questions

What is Bionano Genomics Inc's market cap?

Bionano Genomics Inc's market capitalization is USD 13.43M.

What does Bionano Genomics Inc do?

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia.